The effects of melatonin supplementation on neurobehavioral outcomes and clinical severity...

B Golabi, H Razmaray, S Seyedi-Sahebari… - BMC psychiatry, 2024 - Springer

Background Multiple sclerosis (MS) is a disabling disease of the central nervous system.
People living with MS often have co-existing sleep disorders and cognitive dysfunction. The …

被引用次数：1 相关文章所有 8 个版本

[HTML] mdpi.com

[HTML][HTML] Kynurenines and Inflammation: A Remarkable Axis for Multiple Sclerosis Treatment

P Carrillo-Mora, C Landa-Solís, D Valle-Garcia… - Pharmaceuticals, 2024 - mdpi.com

Multiple sclerosis (MS) is a chronic inflammatory autoimmune neurological disease
characterized by the recurrent appearance of demyelinating lesions and progressive …

12-week melatonin supplementation improved dynamic postural stability and walking performance in persons living with multiple sclerosis: A randomized controlled …

S Jallouli, S Ghroubi, M Damak, S Sakka… - Behavioural brain …, 2025 - Elsevier

Background Persons with multiple sclerosis (PwMS) suffer from sleep disturbances, fatigue
and pain, which can be due, at least in part, to decreased levels of endogenous melatonin …

[PDF][PDF] Effects of melatonin on the management of multiple sclerosis: A scoping review on animal studies

H Bandehagh, F Gozalpour, A Mousavi… - AIMS Medical …, 2024 - aimspress.com

Effects of melatonin on the management of multiple sclerosis: A scoping review on animal
studies Page 1 AIMS Medical Science, 11(2): 137–156. DOI: 10.3934/medsci.2024012 …

被引用次数：2 相关文章所有 2 个版本

[PDF] rheumres.org

[PDF][PDF] Role of melatonin in rheumatoid arthritis: a narrative review

S Naghilou, A Naseri, V Sadra - Rheumatology Research, 2024 - rheumres.org

Melatonin (methoxytryptamine-5-acetyl-N) is the main hormone secreted by the pineal
gland. This hormone is a methoxyindole-synthesized and produced at night under normal …